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While signiﬁcant effort has been dedicated to the characterization of epigenetic changes
associated with prenatal differentiation, relatively little is known about the epigenetic changes
that accompany post-natal differentiation where fully functional differentiated cell types with
limited lifespans arise. Here we sought to address this gap by generating epigenomic and
transcriptional proﬁles from primary human breast cell types isolated from disease-free
human subjects. From these data we deﬁne a comprehensive human breast transcriptional
network, including a set of myoepithelial- and luminal epithelial-speciﬁc intronic retention
events. Intersection of epigenetic states with RNA expression from distinct breast epithelium
lineages demonstrates that mCpG provides a stable record of exonic and intronic usage,
whereas H3K36me3 is dynamic. We ﬁnd a striking asymmetry in epigenomic reprogramming
between luminal and myoepithelial cell types, with the genomes of luminal cells harbouring
more than twice the number of hypomethylated enhancer elements compared with
myoepithelial cells.
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O
ur current concept of epigenetic patterning suggests a
model where sequence-speciﬁc DNA-binding proteins
act in concert with epigenetic regulatory cofactors to
orchestrate a process of cellular differentiation accompanied by
ordered and directional lineage restriction. Studies that have
examined epigenetic lineage restriction have largely focused on
the earliest stages of cellular differentiation where pluripotent
potential is lost1,2. The extent to which these prenatal epigenetic
processes are maintained during the end-stages of post-natal
differentiation is largely unknown. Since epithelial cells within
breast tissue, under the inﬂuence of hormones, mature post-
natally to acquire their functionally different phenotypes, they
present optimal cell sets to study the post-natal epigenetic
changes.
The human breast is composed of ductal epithelial structures
surrounded by various stromal components, consisting primarily
of adipocytes, ﬁbroblasts, immune cells, blood vessels and
extracellular matrix3. Mammary ducts consist of myoepithelial,
luminal epithelial (luminal) and rare progenitor cell types. Cell
type-speciﬁc surface markers allow for the puriﬁcation of these
mammary cell populations that are enriched with functional and
phenotypic characteristics of the in vivo cell type4. Breast
myoepithelial and luminal cells are generated by bipotent or
unipotent differentiation of resident mammary progenitor cells5
and thus provide a framework to investigate epigenetic changes
that accompany normal post-natal epithelial differentiation.
We utilized this framework to examine the molecular events
that accompany post-natal differentiation by generating epige-
nomic and transcriptional proﬁles from primary human breast
cell types isolated from disease-free human subjects. From these
data we deﬁne a comprehensive human breast transcriptional
network including microRNAs (miRNAs), long noncoding RNAs
and coding gene isoforms. We ﬁnd that the degree of intron
retention increases as cells near an end-stage differentiation state
and we deﬁne a set of myoepithelial- and luminal epithelial-
speciﬁc intronic retention events. Intersection of epigenetic states
with RNA expression from distinct breast epithelium lineages
demonstrates that mCpG provides a stable record of exonic and
intronic usage, whereas H3K36me3 is dynamic. Our analysis also
reveals a striking asymmetry in epigenomic reprogramming
between luminal and myoepithelial cell types, which arise from a
common progenitor. The genomes of luminal cells harbour more
than twice the number of hypomethylated enhancer elements
compared with myoepithelial cells and, although the transcrip-
tional complexity of the two cell types is similar, the overall
transcriptional output of luminal cells is B4 times that of
myoepithelial cells. Overall, our analysis provides a comprehen-
sive view of highly puriﬁed genetically matched normal human
mammary cell types and insights into the novel transcriptional
and epigenetic events that deﬁne breast cell differentiation in vivo.
Results
Epigenomic proﬁling. To explore the chromatin landscape of
mammary cells, morphologically normal breast tissue obtained
from disease-free women was dissociated and depleted of lineage-
positive (primarily stromal) cells including endothelial cells,
immune cells and ﬁbroblasts (Fig. 1a and Methods). The
remaining (primarily epithelial) cell population was subjected to
ﬂuorescence-activated cell sorting to 95% purity with established
markers for myoepithelial and luminal epithelial (luminal); CD10
and MUC1, respectively6,7. In addition, we puriﬁed a population
of CD73-expressing cells previously demonstrated to contain a
rare cell population (B1–3%) with stem-like properties8 (stem
like; Fig. 1a and Methods). Variant human mammary epithelial
cells (vHMEC) and mammary ﬁbroblasts were obtained de novo
from cultured mammary tissue as previously described9,10.
Massively parallel sequencing-based assays were employed to
comprehensively annotate the expression and epigenetic states of
these cell types (Fig. 1a and Supplementary Data 1 and Methods).
Breast cell type-speciﬁc gene and exon expression.
Unsupervised clustering of mRNA-seq derived gene and exon-
level expression values revealed expected clustering by cell
type (Supplementary Fig. 1). We observed an average of 1,211
differentially expressed (DE) genes (Fig. 1b and Supplementary
Data 2) and 2,349 DE gene isoforms (Supplementary Fig. 2 and
Supplementary Data 3; 90.5% validation rate, Supplementary
Fig. 3) in equal proportions (up versus down) between the
myoepithelial and luminal cell populations isolated from three
individuals. A signiﬁcant fraction of DE genes (455; hypergeo-
metric P value¼ 0) and isoforms (2,200; hypergeometric P
value¼ 0) overlapped across the three individuals and included
previously documented11 (Supplementary Fig. 4) and novel
myoepithelial- and luminal-speciﬁc transcriptional markers
(Supplementary Data 2) that were conﬁrmed by immuno-
histochemistry (IHC) on matched formalin-ﬁxed, parafﬁn-
embedded breast tissue sections (Supplementary Fig. 5).
Epigenetic signature of exon usage. Epigenetic modiﬁcations,
including mCpG and H3K36me3, are enriched within actively
transcribed gene bodies and have been previously correlated with
exon usage12,13. We conﬁrmed a general correlation between
DNA methylation and exon usage (Fig. 1c; two-sided t-test
P valueo10 18). However, surprisingly, when we restricted our
analysis to cell type-speciﬁc exons (8,630 exons), mCpG levels
between the myoepithelial and luminal cell populations showed
no signiﬁcant differences (Fig. 1c; two-sided t-test P value
40.05). Comparison of mCpG levels and exon usage between
breast cell types and human embryonic stem cells (hESC) further
supported this observation, where exons exclusively expressed in
hESCs were found to retain a mCpG signature in myoepithelial
and luminal epithelial cells (Supplementary Fig. 6; two-sided
t-test P valueo10 4). H3K36me3 levels were found to correlate
with exon usage and, in contrast to mCpG levels, we observed an
increase in H3K36me3 levels for cell type-speciﬁc exons (Fig. 1d;
two-sided t-test P value¼ 10 25 and Supplementary Fig. 7).
Taken together, these results conﬁrm that utilized exons generally
have increased levels of mCpG and H3K36me3 and suggest that
once mCpG is established at an exon–intron boundary, it is stably
inherited through subsequent differentiations regardless of its
expression. In contrast, H3K36me3 is dynamically gained and lost
as a consequence of expression in a given cell type (Fig. 1e).
Intronic retention levels increase in post-natal cell types. Intron
retention is a widely observed but poorly studied phenomenon in
both normal and transformed breast tissue14, where incomplete
splicing leads to the retention of intronic sequences from pre-
messenger RNAs that can target the resulting transcript for
nonsense-mediated decay15. We found evidence for 3,693
retained introns in myoepithelial and luminal epithelial cell
types of which the majority (67%) was cell type-speciﬁc using our
thresholds (Supplementary Data 4). Strikingly, we found that the
degree of intronic retention increased with differentiation state
(Fig. 2a and Supplementary Fig. 8). Within breast cell types,
luminal epithelial cells were found to express the largest number
of intronic retained mRNAs with47 times the number of events
observed in myoepithelial cells (2,166 versus 304, respectively).
To provide a possible mechanistic explanation, we examined the
expression of the splicesome and SWI/SNF complex members
and found that, similar to myeloid differentiation15, their
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expression was almost exclusively downregulated during
differentiation (Fig. 2a lower panel). Retained introns were
found to have increased CpG density overall (Fig. 2b; two-sided
t-test P value o10 30), and we observed a reduction (two-sided
t-test P value o10 13) in the degree of mCpG changes across
exon–intron boundaries for retained introns. This observation
supports a link between exon–intron boundary DNA methylation
and exon splicing, which would not be expected to occur to the
same degree when the ﬂanking intron is retained (Fig. 2b and
Supplementary Fig. 9). We also observed an increase in DNA
methylation within retained introns. This effect was more
pronounced in luminal epithelial cells, in which we also
observed higher intron retention rates and expression levels,
suggesting that this phenotype was not simply a reﬂection of an
increase in CpG density. We validated a subset of intronic
retention events by quantitative reverse transcription PCR
(Supplementary Figs 10 and 11). Functional analysis of the
intron-retained genes showed signiﬁcant enrichment for genes
encoding ‘phosphoproteins’ in both the cell types (Luminal;
Benjamini P value o10 31 and Myoepithelial; Benjamini
P value o10 23). As previously reported in granulocytes15, we
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Figure 1 | Differential expression and isoform analysis. (a) Experimental overview (b) DE genes in myoepithelial and luminal (lum) epithelial cell types
across three donors, luminal upregulated (red), myoepithelial (myo) upregulated (green). (c) Exon–intron junction mCpGs provide an inherited signature of
exon expression. Average number of CpGs (black, bottom panel) and average mCpG levels (whole-genome bisulphite shotgun, 20 bp bins) at exon
junctions þ / 200bp in luminal (solid line with round dots) and myoepithelial (dashed line with triangles). Exons are divided into four groups namely:
(1) exons expressed in both the cell types (exon reads per kilobase of transcript per million reads mapped (RPKM) 40.1 in luminal and myoepithelial
RM084, purple); (2) luminal-speciﬁc exons (isoform exons expressed in luminal but not in myoepithelial, red); (3) myoepithelial-speciﬁc exons (isoform
exons expressed in myoepithelial but not in luminal, green) and (4) exons not expressed in either cell types (all other exons, blue). A statistical signiﬁcant
difference was observed between the not expressed exons and all other groups, t-test P valueo10 18. All other comparisons show weak or no statistically
signiﬁcant difference. (d) H3K36me3 density in exon bodies provides a transient record of exon expression. Average H3K36me3 signal levels for exons in
expressed genes (gene RPKM40.1) in luminal RM080 (red) and myoepithelial RM080 (green). Exons are broken down into four groups namely: (1) exons
expressed in both the cell types (exon RPKM40.1 in luminal and myoepithelial); (2) luminal-speciﬁc exons (isoform exons expressed in luminal but not in
myoepithelial); (3) myoepithelial-speciﬁc exons (isoform exons expressed in myoepithelial but not in luminal); and (4) exons not expressed in either cell
types (all other exons). Fold enrichment of average H3K36me3 signal levels within exons revealed an increase H3K36me3 signals in cell type-speciﬁc exons
in corresponding cell populations. (e) Model of inherited and transient epigenetic exon marking. Exon boundary DNA methylation (black dot) and exon
body H3K36me3 (red ﬂag) marking of exons in luminal and myoepithelial cell populations.
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mRNAs that would be predicted to undergo nonsense-mediated
decay. In support of this prediction, we conﬁrmed the absence
of detectable protein by IHC for the NOXA1 transcript
(Fig. 2c). Taken together, these results suggest that intron
retention may play a role in deﬁning mammary cell types,
particularly luminal cells, and, more generally, that intronic
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Breast cell type-speciﬁc noncoding RNA. Noncoding RNAs are
key regulators of diverse cellular processes16 that can interact
directly with the epigenetic machinery and may be prognostic in
breast cancer17. We identiﬁed 936 unique miRNAs expressed at
similar distributions across the ﬁve mammary-derived cell types,
including a core set of 29 that were highly expressed
(41,000 reads per million (RPM)) across myoepithelial, luminal
epithelial and stem-like cell types (Supplementary Fig. 12b and
Supplementary Data 5). Hierarchical clustering demonstrated
expected cell type relationships (Supplementary Fig. 12c), and cell
type-speciﬁc miRNAs were identiﬁed with a majority being
expressed in vHMECs (Fig. 2e). We also identiﬁed 1,870
expressed lincRNAs (Supplementary Fig. 13 and Supplementary
Data 6) and 82 cell type-speciﬁc lincRNAs across the mammary
cell types with myoepithelial cells showing the smallest number of
cell type-speciﬁc events (Fig. 2f and Supplementary Data 7).
Restricting our comparison to myoepithelial and luminal cells, we
identiﬁed 206 DE noncoding RNAs, including 130 lincRNAs and
76 antisense transcripts. Among the DE lincRNAs, MALAT
(NEAT2), a critical regulator of metastasis in epithelial cancers18,
was overexpressed in normal luminal cells suggesting that its
expression is not solely restricted to the metastatic potential in
epithelial lineages. An imprinted region of 14q32.3, that encodes
maternally expressed noncoding MEG3 and MEG8 transcripts
and 54 miRNAs expressed from the maternally inherited
homologue, was transcriptionally silenced in luminal cells
(Supplementary Fig. 14). Loss of expression of the MEG3
cluster through loss of heterozygosity and promoter
hypermethylation is frequent in epithelial cancers19. Our results
suggest that MEG3 transcriptional repression is associated with
normal epithelial differentiation and provide a novel intergenic
differentially methylated region (DMR) that may be responsible
for its cell type-speciﬁc regulation (Supplementary Fig. 14).
DNA methylation deﬁnes a breast cell regulatory network. To
discover putative regulatory elements including actively bound
enhancers20, we identiﬁed 26,601 and 53,751 DNA unmethylated
regions (UMR) in myoepithelial and luminal epithelial cells from
whole-genome bisulphite data sets, respectively21 (Supplementary
Fig. 15 and Supplementary Data 8). We validated these UMRs
against orthologonal MeDIP-seq and MRE-seq data sets
(Supplementary Fig. 16). Nearest gene-based analysis22 of the
UMRs revealed highly signiﬁcant enrichment for the expected
pathways, including smooth muscle contraction (binomial false
discovery rate (FDR) Q value¼ 10 71) for myoepithelial cells
and mammary gland epithelium development (binomial FDR Q
value¼ 10 72) for luminal epithelial cells (Supplementary
Fig. 17). The UMRs overlapped almost exclusively with
enhancer chromatin states (Supplementary Fig. 18), displayed
signiﬁcant overlap with ENCODE transcription factor (TF)
chromatin immunoprecipitation (ChIP)-seq regions (luminal
epithelial: 58%, myoepithelial: 60%, with B20% expected by
chance), and intersection with genome-wide association study
alleles revealed a direct overlap with 10 single-nucleotide
polymorphisms recently associated with the breast cancer risk
loci (Supplementary Fig. 19, Supplementary Data 9), suggesting
that these UMR regions are highly enriched in regulatory
elements that deﬁne the breast cell types.
Regulatory asymmetry across breast cell types. Strikingly, we
observed an asymmetry in the number of regulatory UMRs
between breast cell types with 51 transcription factors having at
least two times more sites in luminal than myoepithelial UMRs,
while no TFs were more abundant in myoepithelial UMRs
(Supplementary Data 10). The top three TFs (FOXA1, GATA3
and ZNF217) ranked by abundance of UMR-deﬁned regulatory
elements, are critical regulators of luminal cell biology and were at
least eight times more abundant in luminal versus myoepithelial
cells (Fig. 3a). To explore how these regulatory elements could
inﬂuence the breast cell transcriptional programme, we associated
them with genes and found a highly signiﬁcant overlap (81%)
between the cell type-speciﬁc UMRs and proximal upregulated
DE genes (Fig. 3b). Interestingly, this association was highly
directional with the majority (90.3%) of proximal UMRs asso-
ciated with increased transcription in their respective cell types
(Fig. 3b,d). This directionality was reduced for distal UMRs. Only
6% of the commonly expressed genes were found to be associated
with cell type-speciﬁc proximal UMRs, highlighting their
importance in deﬁning a cell type-speciﬁc transcriptional pro-
gramme (Fig. 3c).
The regulatory asymmetry observed between luminal and
myoepithelial cells prompted us to examine the overall transcrip-
tional output of these two cell types. While luminal cells
demonstrated a higher overall intronic retention rate (Fig. 2a),
we did not observe signiﬁcant differences in the degree of gene
association or in the number and type of expressed transcripts
(including TFs) in the two breast cell types. Notably, however,
normalization inherent to RNA-seq analysis masks the ability to
determine the differences in the total transcriptional output
between the cell types23. Therefore, to examine this effect directly,
we calculated per cell RNA yields across myoepithelial and
luminal cell populations extracted from three human subjects and
Figure 2 | Intron retention and mammary cell type-speciﬁc miRNAs and long noncoding RNAs. (a) Upper panel—enumeration of expressed protein
coding (pc) and noncoding (nc) genes, expressed introns and intron/exon ratio from hESCs (left) to luminal (lum) epithelial cells (right). Expression is
deﬁned by an RPKM41. Lower panel—mRNA expression of U1 and U2 spliceosome subunits and SWI/SNF complex components in hESC derived CD56þ
ectoderm cultured cells compared with RM084 luminal cells. (b) DNA methylation proﬁle at intron boundaries. Average DNA methylation level proﬁle at
intron 50 and 30 þ / 200bp with 20-bp bins in luminal RM066 (top panel) and myoepithelial RM045 (third panel) WGBS libraries. Average number of
CpGs (second and fourth panel). Introns are divided into retained introns (red in luminal and green in myoepithelial (myo)) and not retained introns (blue)
according to intron retention analysis in RM084. Differences in DNA methylation level across exon–intron boundaries are calculated by subtracting
minimum DNA methylation level within introns (intron 50 þ 200bp or 30  200bp, valley) from maximum DNA methylation level within exons (intron
50  200bp or 30 þ 200bp, peak) and P values of t-test between retained introns and not retained introns are shown in DNA methylation panels. P values
for CpG density panels are calculated by t-test on average No. of CpGs across the 400-bp boundaries between retained introns and not retained introns.
(c) Visualization at UCSC genome browser of NOXA1 retained intron event (hg19 chr9:140327716–140327904—highlighted in blue) in luminal epithelial
(red tracks) and myoepithelial cells (green tracks) across different assays: RNA-seq (RPKM values), WGBS-seq (CpG fractional methylation) and
H3K36me3 ChIP-seq signal track. The ‘CG’ track shows the location of CpG dinucleotides. (d) Boxplots show NOXA1 expression level (log10(RPKM)) in
luminal epithelial (left) and myoepithelial (right) cell types. Validation of the loss of detectable NOXA1 protein in both breast cell types across RM071,
RM066 and RM084 individuals with IHC compared to kidney used as a positive control. Scale bar: 50mm. (e) Entropy heatmap of cell type-speciﬁc
miRNAs across mammary cell types. (f) Entropy heatmap of cell type-speciﬁc lincRNAs (Supplementary Data 7) across mammary cell types. Fibr, ﬁbroblast.
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found that luminal cells expressed 3.7þ / 1.3 times the amount
of total RNA compared with myoepithelial cells (Fig. 3e). Taken
together, these results reveal a striking regulatory asymmetry
between myoepithelial and luminal cells that is correlated
with transcriptional ampliﬁcation in luminal cells. While
transcriptional ampliﬁcation has been demonstrated in c-MYC
driven tumour cell types24, to our knowledge this is the ﬁrst
reported case of such an event occurring as a product of normal
cellular differentiation.
Discussion
Our analysis of primary normal human breast cell types has
revealed novel insights into the transcriptional and epigenetic
events that specify them. We provide a comprehensive database
of the DE transcripts including isoforms for puriﬁed populations
of normal breast epithelium, ﬁbroblasts and derived vHMECs.
Intersection of exon expression with epigenetic states conﬁrmed
that utilized exons generally have increased levels of mCpG and
H3K36me3 and suggested that once mCpG is established at an
exon–intron boundary it is stably inherited through subsequent
differentiations, whereas H3K36me3 is transient. This pattern is
consistent with a model where mCpG and H3K36me3 accumu-
late at the exon boundaries as a consequence of RNA polymerase
pausing, and thus local enrichment of SETD2 (ref. 25) and
DNMT3b (ref. 26), at the intron/exon boundaries27. Once
established mCpG would be expected to be relatively stable
through cell divisions, whereas H3K36me3 would be actively or
passively lost.
Our analysis also revealed a potential role for intronic retention
during breast cell differentiation, particularly in luminal cells,
and, more generally, that intronic retention may be a common
post-natal regulatory mechanism. We provide a comprehensive
database of noncoding transcripts and observe that the imprinted
MEG3 locus is bi-alleically silenced during normal epithelial
differentiation and provide evidence for a novel intergenic DMR
that may responsible for its cell type-speciﬁc regulation.
We deﬁne a regulatory network for luminal and myoepithelial
cells and provide an intersection with breast cancer genome-wide
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Figure 3 | Regulatory asymmetry between myoepithelial and luminal cell types. (a) Plot of the relative abundance of TF binding sites overlapping UMRs
in luminal (lum) and myoepithelial (myo) cells reveals regulatory asymmetry between the breast cell types. Red line represents total UMR abundance.
(b) Fraction of DE genes (upregulated in luminal: red, upregulated in myoepithelial: green) associated with luminal (bottom panel) and myoepithelial
(top panel) UMRs. Left panel shows proximal UMRs (UMRs within transcriptional start site (TSS) þ / 2 kb), and right panel shows distal UMRs (TSS
þ / 20 kb). (c) Fraction of DE genes (upregulated in luminal: red, upregulated in myoepithelial: green) associated with both luminal and myoepithelial
UMRs. Left panel shows proximal UMRs (UMRs within TSS þ / 2 kb) and right panel shows distal UMRs (TSS þ / 20 kb). (d) Differential expression
(upregulated in luminal: red, upregulated in myoepithelial: green) of proximal UMRs overlapping with binding sites of luminal enriched (FoxA1, Gata3
and Znf217), and myoepithelial enriched TFs (Egr1). The size and shade of the circles represents fold change between luminal and myoepithelial gene
expression on the log2 scale. (e) RNA yield (microgram per million cells) from luminal (red) and myoepithelial (green) cells extracted from three
individuals.
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elements could be associated with cell type-speciﬁc transcripts
and that this association was highly directional, with 490% of
proximal UMRs associated with increased transcription in their
respective cell types. In this context, we observed a striking
regulatory asymmetry between myoepithelial and luminal cells
and correlated this with an overall increase in the cell-normalized
transcriptional output in luminal cells24.
Taken together, our ﬁndings provide novel mechanistic clues
about the events that contribute to normal epithelial differentia-
tion and provide a comprehensive reference for future studies of
disease.
Methods
Human tissue samples. Human breast tissues, obtained from disease-free women
undergoing reduction mammoplasty after informed consent, were provided by the
Cooperative Human Tissue Network (Nashville, TN) and the Kaiser Foundation
Research Institute (Oakland, CA). Samples were identiﬁed through unlinked codes
in accordance with the federal Health Insurance Portability and Accountability Act
(HIPAA) guidelines. The information obtained about human tissue samples,
including age, ethnicity and parity/gravidity, met the HIPAA guidelines. All tissues
used in this study were devoid of visible disease, bacterial, fungal or viral con-
tamination and exhibited a normal diploid 46, XX karyotype. Accrual and use of
the breast tissues to conduct the studies described above were approved by the
UCSF Committee on Human Research under Institutional Review Board protocol
No. 10–01563.
Dissociation of breast tissue. Breast tissue was dissociated mechanically and
enzymatically, as previously described8,9. In brief, tissue was minced and
dissociated in Roswell Park Memorial Institute medium (RPMI) 1640 with
L-glutamine and 25mM Hepes (Fisher; cat no. MT10041CV) supplemented with
10% (v/v) fetal bovine serum (FBS; JR Scientiﬁc; cat no. 43603), 100 unitsml 1
penicillin, 100 mgml 1 streptomycin SO4, 0.25 mgml 1 fungizone, gentamycin
(Lonza; cat no. CC4081G), 0.88mgml 1 collagenase-2 (Worthington; cat no.
CLS-2) and 0.40mgml 1 hyaluronidase (Sigma; cat no. H3506-SG) at 37 C for
16 h. The cell suspension was centrifuged at 394 g for 10min followed by a wash
with RPMI 1640/10% FBS. Clusters enriched in epithelial cells (referred to as
organoids) were recovered after serial ﬁltration through a 150-mm nylon mesh
(Fisher; cat no. NC9445658) and a 40-mm nylon mesh (Fisher; cat no. NC9860187).
The ﬁnal ﬁltrate contained the mammary stromal cells, consisting primarily of
ﬁbroblasts and endothelial cells. Following centrifugation at 290 g for 5min, the
epithelial organoids and ﬁltrate were frozen for long-term storage. To generate
single-cell suspensions, epithelial organoids were further digested for 5min in
0.5 g l 1 trypsin-0.2 g l 1 EDTA-0.58 g l 1 NaHCO3 and 1min in dispase-
DNAse I (Stem Cell Technologies; cat no. 7913 and 7900, respectively) then ﬁltered
through a 40-mm cell strainer (Fisher; cat no. 087711). Fibroblasts were generated
by culture of the ﬁltrate in RPMI 1640 supplemented with 10% FBS and antibiotics
and fungicides28. vHMECs were generated by culturing epithelial organoids in
mammary epithelial cell growth medium (MEGM - Lonza; cat no. CC-03051)
supplemented with antibiotics and fungicides9.
Karyotyping. Karyotyping was carried out at Molecular Diagnostic Services Inc.
(San Diego, CA). In brief, primary breast cells obtained from the ﬁltrate fraction
described above were allowed to grow to 80% conﬂuency. Mitotic division was
arrested by treating cells with 75 ngml 1 colcemid for 18.5 h. Following treatment,
cells were collected with trypsin–EDTA, treated with a hypotonic solution and
ﬁxed in methanol/acetic acid. Metaphase spreads were prepared from the ﬁxed cells
and stained to observe chromosomal G bands. For each tissue sample, 20 meta-
phase spreads were counted, 5 of which were analysed and karyotyped (Fig. 1a). In
total, six independent donor samples were karyotyped. All samples analysed yiel-
ded a diploid 46, XX karyotype.
Cell cycle analysis. Cell cycle analysis was carried out as previously described29.
In brief, an aliquot of primary cells similar to those used for karyotyping was
metabolically labelled with 10 mM bromodeoxyuridine (BrdU) at 37 C for 4 h,
trypsinized and ﬁxed with ice cold 95% ethanol. Fixed cells were incubated with
0.08% pepsin (w/v in 0.1N HCl) at 37 C for 25min with frequent shaking. Nuclei
were isolated after cell digestion with 0.08% pepsin (w/v in 0.1 N HCl) at 37 C for
25min. Isolated nuclei were stained with an anti-BrdU antibody coupled to
ﬂuorescein isothiocyanate diluted 1:5 in 150mM NaCl, 10mM Hepes, pH 7.4, 4%
fetal calf serum, 0.1% sodium azide (IFA) buffer over ice and in the dark for
30min. Nuclei were washed once with 1ml IFA bufferþ 0.5% Tween-20 and
incubated with IFA bufferþ 5 mgml 1 RNAseþ 50mgml 1 propidium iodide at
37 C for 15min. Samples were placed on ice for 15min and analysed by ﬂow
cytometry on a FACSAria Sorter (Becton Dickinson). All analysed events were
gated to remove debris and aggregates.
Flow cytometry staining for cell sorting. The single-cell suspension obtained as
described above was stained for cell sorting with a cocktail of biotinylated anti-
bodies for lineage markers, anti-CD2, -CD3, -CD16, -CD64 (BD Biosciences; cat
no. 555325, 555338, 555405 and 555526), CD31 (Invitrogen; cat no.
MHCD3115), CD45 and CD140b (BioLegend; cat no. 304003 and 323604) to
speciﬁcally remove hematopoietic, endothelial and leukocyte lineage cells. Cells
were stained for 20min at room temperature in PBS with 1% BSA, followed by
washing in PBS with 1% BSA. Biotinylated primary antibodies were revealed
with an anti-human secondary antibody labelled with streptavidin-Paciﬁc Blue
conjugate (Invitrogen; cat no. S11222). The lineage-positive and negative cell
populations were sorted using a FACSAria II cell sorter (BD Biosciences). The
lineage-positive population was discarded. The lineage-negative cell population was
incubated simultaneously with three human-speciﬁc primary antibodies (anti
CD10 labelled with Phycoerythrin (PE) coupled to Cy7 (BD Biosciences; cat no.
341092), anti-MUC1 labelled with ﬂuorescein isothiocyanate (BD Biosciences; cat
no. 559774) and anti-CD73 labelled with PE (BD Biosciences; cat no. 550257) for
20min at room temperature in PBS with 1% BSA, followed by washing in PBS with
1% BSA. Cells were then sorted as described above.
Immunohistochemistry. Human disease-free breast tissues were ﬁxed in formalin
and parafﬁn-embedded using a standard protocol. Parafﬁn-embedded tissues were
cut into 4-mm serial sections, laid on Polysine microscope slides (Thermo Scientiﬁc,
cat no. 6776215), deparafﬁnized and rehydrated using standard procedures. All
steps were carried out at room temperature except when noted. Antigen retrieval
was carried out by microwaving the tissue sections in citrate buffer, pH 6.0, for
10min (for the detection of CD10, MUC1, claudin 4 and NOXA1) or in EDTA at
pH 8.0 for 10min (for the detection of anoctamin 1/TMEM16A). Sections were
then incubated with either a primary mouse monoclonal antibody against CD10
(Thermo Scientiﬁc; cat no. MS-728-S0, clone 56C6) diluted 1/20 or a primary
mouse monoclonal antibody against MUC1 (Upstate Biotechnology; cat no.
05–653, clone 232A) diluted 1/200 or a primary mouse monoclonal antibody
against claudin 4 (Life Technologies; cat no. 18–7341, clone 3E2C1) diluted 1/200 or
a primary rabbit polyclonal antibody against anoctamin 1/TMEM16A (Abcam; cat
no. ab53212) diluted 1/1,600 or a primary rabbit polyclonal antibody against
NOXA1 (Novus Biologicals; cat no. NBP1–92197) diluted 1/100 overnight at 4 C.
The staining was visualized after incubation with the HRP polymer kit (Ultravision
LP kit, Thermo Scientiﬁc, cat no. TL-125 HLS) for 30min according to the man-
ufacturer’s instructions and with diaminobenzidine substrate (Genemed; cat no.
520017) for 5min. Tissue sections were counterstained with hematoxylin and
mounted. Stained sections were imaged at  10,  20 and  40 magniﬁcation
using a DS-Ri1 Nikon colour digital camera mounted to a DMLB Leica microscope.
RNA sequencing. Standard operating procedures for RNA-seq library construction
are available (http://www.roadmapepigenomics.org/protocols/type/experimental/)
or by request. RNA-seq library construction involves the following standard oper-
ating procedures (SOPs) in order: (1) Puriﬁcation of polyAþ mRNA and
mRNA( ) ﬂowthrough total RNA using MultiMACS 96 separation unit; (2)
strand-speciﬁc 96-well complementary DNA (cDNA) synthesis; (3) strand-speciﬁc
96-well library construction for Illumina sequencing. In brief, polyAþ RNA was
puriﬁed using the MACS mRNA isolation kit (Miltenyi Biotec, Bergisch Gladbach,
Germany), from 2–10mg of total RNA with a RIN 4¼ 7 (Agilent Bioanalyzer) as
per the manufacturer’s instructions. The process included on-column DNaseI
treatment (Invitrogen, Carlsbad, CA, USA). Double-stranded cDNA was synthe-
sized from the puriﬁed polyAþ RNA using the Superscript II Double-Stranded
cDNA Synthesis kit (Invitrogen) and 200 ng random hexamers (Invitrogen). After
ﬁrst strand synthesis, dNTPs were removed using 2 volumes of AMPure XP beads
(Beckman Genomics, Danvers, MA, USA). GeneAmp (Invitrogen) 12.5mM dNTPs
blend (2.5mM dCTP, 2.5mM dGTP, 2.5mM dATP, 5.0mM dUTP) was used in
the second-strand synthesis mixture in the presence of 2mg of ActinomycinD.
Double-stranded cDNA was puriﬁed using 2 volumes of Ampure XP beads, frag-
mented using Covaris E series shearing (20% duty cycle, Intensity 5, 55 s), and used
for paired-end sequencing library preparation (Illumina). Before library ampliﬁca-
tion uridine digestion was performed at 37 C for 30min following with 10min at
95 C in Qiagen Elution buffer (10mM Tris–Cl, pH 8.5) with 5 units of Uracil-N-
Glycosylase (UNG: AmpErase). The resulting single-stranded sequencing library
was ampliﬁed by PCR (10–13 cycles) to add Illumina P5 and P7 sequences for
cluster generation. PCR products were puriﬁed on Qiaquick MinElute columns
(Qiagen, Mississauga, ON) and assessed and quantiﬁed using an Agilent DNA 1000
series II assay and Qubit ﬂuorometer (Invitrogen, Carlsbad, CA), respectively.
Libraries were sequenced using paired-end 76 nt sequencing chemistry on a cBot
and Illumina GAiix or HiSeq 2000 following the manufacture’s protocols (Illumina).
RNA-seq pair-end reads are aligned to a transcriptome reference consisting of
the reference genome extended by the annotated exon–exon junctions30. To
generate transcriptome reference we used the JAGuaR v 1.7.6 pipeline31. Reads
aligned to a custom transcriptome reference (build from NCBI GRCh37-lite
reference and Ensembl v65 (GenCode v10) annotations) were then ‘repositioned’
on to genomic coordinates, transforming reads that span exon–exon junctions into
large-gapped alignments. Using repositioned reads we generated genome-wide
coverage proﬁles (wiggled ﬁles) using a custom BAM2WIG java program (http://
www.epigenomes.ca/tools.html) for further analysis and visualization in genome
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browsers. To generate proﬁles we included pairs that are marked as duplicated as
well as pairs that are mapped in multiple genomic locations.
A custom RNA-seq QC and analysis pipeline was applied to the generated
proﬁles and a number QC metrics were calculated to assess the quality of RNA-seq
library such as intron–exon ratio, intergenic reads fraction, strand speciﬁcity
(for stranded RNA-seq protocols), 30-50 bias, GC bias and reads per kilobase of
transcript per million reads mapped (RPKM) discovery rate (see Supplementary
Data 11). To quantify the exon and gene expression we calculated modiﬁed RPKM
metrics32. For the normalization factor in RPKM calculations we used the total
number of reads aligned into coding exons and excluded reads from mitochondrial
genome as well as reads falling into genes coding for ribosomal proteins as well as
reads falling into top 0.5% expressed exons. RPKM for a gene was calculated using
the total number of reads aligned into its all merged exons normalized by total
exonic length. The resulting ﬁles contain RPKM values for all annotated exons and
coding and noncoding genes, as well as introns (Supplementary Data 12 and 13).
We also report the coordinates of all signiﬁcant intergenic RNA-seq clusters not
overlapping the annotated genes.
Exon-level-normalized RPKM were used to identify cell type-speciﬁc isoforms
(Supplementary Data 14). Pairwise comparisons between different cell types within
the same individual were performed to identify DE exons using a custom DEﬁne
matlab tool (FDR cutoff¼ 0.015). Expressed exons were deﬁned as those with
RPKM Z10% of gene RPKM; unexpressed exons were deﬁned as those with
RPKMr1% of gene RPKM; and the exons in between (1B10% gene RPKM) were
discarded to ﬁlter out most false positives. Isoforms for each pairwise comparison
were identiﬁed as genes with DE exons expressed in only one of the two samples.
DE genes were excluded from this list. Functional analysis of myoepthelial and
luminal isoforms revealed the enrichment of genes encoding proteins involved in
intracellular signalling (Supplementary Fig. 20), while no functional enrichment
was found for the individual-speciﬁc isoforms (Supplementary Data 3). In addition,
exon–exon junction coverages were calculated from RNA-seq BAM ﬁles. On
average, 38.6% of the identiﬁed isoforms demonstrated junction coverage due to
the difﬁculty in placing sequence reads that span exon–exon junctions, and among
them 87.3% isoform genes have support from junction reads (junction RPKM
40.1 in one sample and o0.1 in the other, Supplementary Data 3). For strand-
speciﬁc libraries (RM084) in particular, we have much higher junction coverage
(53.7%) and junction support (99.3%). Restricting our analysis to strand-speciﬁc
libraries, we found that cassette exons are enriched gene boundaries ends
(Supplementary Fig. 21), and that isoform genes are expressed at a lower level in
general (Supplementary Fig. 22).
Intron-level-normalized RPKM and normalized coverage were used to identify
retained introns in all cell/tissue types. Expressed introns were ﬁrst preﬁltered as
those with RPKM 41. The retained introns were deﬁned as those with RPKM
45% of the protein coding gene RPKM and with normalized coverage 430% of
the ﬂanking exons normalized coverage. Retained introns also have at least 90% of
their sequence covered by at least one read. Introns that overlap exons on the
opposite strand (18902 introns out of 257013) were excluded from the intron
retention analysis to normalize across strand-speciﬁc and non strand-speciﬁc
libraries.
miRNA sequencing. Standard operating procedures for RNA-seq library
construction are available (http://www.roadmapepigenomics.org/protocols/type/
experimental/) or by request. miRNA-seq library construction involves the
following SOPs in order: (1) Puriﬁcation of polyAþ mRNA and mRNA( )
ﬂowthrough total RNA using MultiMACS 96 separation unit; (2) miRNA3—plate
format miRNA library construction. In brief, ﬂowthrough total MultiMACS RNA
was recovered by ethanol precipitation and arrayed into 96-well plates, with
controls as described below. Flowthrough RNA quality was checked for a subset of
samples using an Agilent Bioanalyzer RNA nano chip. An adenylated 30 adapter
was ligated using a truncated T4 RNA ligase2 (NEB Canada, cat. M0242L) with an
incubation of 1 h at 22 C. An RNA 50 adapter was then added, using a T4 RNA
ligase (Ambion USA, cat. AM2141) and ATP, and is incubated at 37 C for 1 h.
Following ligation 1st strand cDNA is synthesized using Superscript II reverse
transcriptase (Invitrogen, cat.18064 014). The resulting product was PCR ampliﬁed
using the 30 PCR primer (50-CAAGCAGAAGACGGCATACGAGAT-30) and an
indexed 50 PCR primer (50-AATGATACGGCGACCACCGACAGNNNNNNGT
TCAGAGTTCTACAGTCCGA-30), Phusion Hot Start High Fidelity DNA poly-
merase (NEB Canada, cat. F-540 l), buffer, dNTPs and dimethylsulphoxide
(DMSO). PCR is run at 98 C for 30 s, followed by 15 cycles of 98 C for 15 s,
62 C for 30 s and 72 C for 15 s, and ﬁnally a 5min incubation at 72 C. Library
quality was assessed on a Caliper LabChipGX DNA chip. PCR products were then
pooled (up to 16 per pool) and size selected by agarose electrophoresis to remove
larger cDNA fragments and smaller adapter contaminants. After size selection,
each pool was ethanol precipitated, quality checked using an Agilent Bioanalyzer
DNA 1000 chip and quantiﬁed using a Qubit ﬂuorometer (Invitrogen, cat.
Q32854). Each pool was then diluted to a target concentration for cluster
generation and loaded into a single lane of an Illumina GAIIx or HiSeq 2000 ﬂow
cell. Clusters are generated, and lanes sequenced with a 31-bp main read for the
insert and a 7-bp read for the index. The resulting sequences were separated into
individual samples based on the index read sequences and assessed for quality.
Adapter sequence was then trimmed off using custom scripts, and the trimmed
reads for each sample were aligned to the NCBI GRCh37-lite reference genome
using Burrows–Wheeler alignment (BWA) as described in ref. 33 (see
Supplementary Data 5 and 15).
ChIP sequencing. Standard operating procedures for ChIP-seq library construc-
tion are available (http://www.roadmapepigenomics.org/protocols/type/experi-
mental/) or by request. ChIP-seq library construction involves the following SOPs
in order: (1) Crosslinking of frozen cell pellet; (2) DNA sonication using Sonic
Dismembrator 550; (3) SLX-PET protocol for Illumina sample preparation.
Antibodies used in this study were subjected to rigorous quality assessment to meet
the reference epigenome mapping quality standards (http://www.roadmapepigen-
omics.org/protocols) including western blot of whole-cell extracts, 384 peptide
dot blot (Active Motif MODiﬁed Histone Peptide Array) and ChIP-seq using
control cell pellets (HL60). Antibody vendor, catalogue number and lot are
provided along with ChIP-seq library construction details as part of the metadata
associated with all ChIP-seq data sets and available through GEO and the
NCBI epigenomics portals (for example, http://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?acc=GSM613886). Final library distributions were calculated using an
Agilent Bioanalyzer and quantiﬁed by ﬂuorometric quantiﬁcation (Qubit, Life
Technologies). Libraries were sequenced using single-end 76 nt sequencing
chemistry on an Illumina GAiix or HiSeq 2000 following the manufacturer’s pro-
tocols (Illumina) as either single or multiplex using custom index adapters added
during library construction.
Raw sequences were examined for quality, sample swap and reagent
contamination using custom in house scripts. Sequence reads were aligned to NCBI
GRCh37-lite reference using BWA 0.5.7 (ref. 34) and default parameters, and
assessed for overall quality using Findpeaks35. Aligned reads were directionally
extended by the average insert size of the DNA fragments for a given library
estimated from Agilent Bioanalyzer (Agilent) proﬁles measured during library
construction and varied between B130 and 250 bp. Custom java program
(BAM2WIG) was used to generate wig ﬁles for downstream analysis and
visualization. Reads with BWA mapping quality scores o5 were discarded and
reads that aligned to the same genomic coordinate were counted only once in the
proﬁle generation.
Methylated DNA immunoprecipitation sequencing. DNA (2–5 mg) was soni-
cated to B100–500 bp with a Bioruptor sonicator (Diagenode). Sonicated DNA
was end-repaired, A-tailed and ligated to single-end adapters following the stan-
dard Illumina protocol. After agarose sized-selection to remove unligated adapters,
adapter-ligated DNA was used for each immunoprecipitation using a mouse
monoclonal anti-methylcytidine antibody (1 mgml 1, Eurogentec, catalogue no.
BI-MECY-0100). DNA was heat-denatured at 95 C for 10min, rapidly cooled on
ice, and immunoprecipitated with 1 ml primary antibody per microgram of DNA
overnight at 4 C with rocking agitation in 500 ml IP buffer (10mM sodium
phosphate buffer, pH 7.0, 140mM NaCl and 0.05% Triton X-100). To recover the
immunoabsorbed DNA fragments, 1 ml of rabbit anti-mouse IgG secondary anti-
body (2.5 mgml 1, Jackson Immunoresearch) and 100 ml Protein A/G beads
(Pierce Biotechnology) were added and incubated for an additional 2 h at 4 C with
agitation. After immunoprecipitation, a total of six IP washes were performed with
ice cold IP buffer. A non-speciﬁc mouse IgG IP (Jackson Immunoresearch) was
performed in parallel to methyl DNA IP as a negative control. Washed beads were
resuspended in Tris-EDTA buffer (TE) with 0.25% SDS and 0.25 mgml 1 pro-
teinase K for 2 h at 55 C and then allowed to cool to room temperature. MeDIP
and supernatant DNA were puriﬁed using Qiagen MinElute columns and eluted in
16 ml EB (Qiagen, USA). Fifteen cycles of PCR were performed on 5 ml of the
immunoprecipitated DNA using the single-end Illumina PCR primers. The
resulting reactions were puriﬁed over Qiagen MinElute columns, after which a ﬁnal
size selection (192–392 bp) was performed by electrophoresis in 2% agarose.
Libraries were quality controlled by spectrophotometry and Agilent DNA Bioa-
nalyzer analysis. An aliquot of each library was diluted in EB to 5 ng ml 1 and 1 ml
used as template in four independent PCR reactions to conﬁrm the enrichment of
methylated and de-enrichment of unmethylated sequences, compared with 5 ng of
the input (sonicated DNA). Two positive controls (SNRPN and MAGEA1 pro-
moters) and two negative controls (a CpG-less sequence on Chr15 and GAPDH
promoter) were ampliﬁed. Cycling was 95 C for 30 s, 58 C for 30 s, 72 C for 30 s
with 30 cycles. PCR products were visualized by 1.8% agarose gel electrophoresis.
Methylation sensitive restriction enzyme sequencing. Three parallel digests
were performed (HpaII, AciI and Hin6I; Fermentas), each with 1 mg of DNA. Five
units of enzyme per microgram DNA were added and incubated at 37 C in Fer-
mentas ‘Tango’ buffer for 3 h. A second dose of enzyme was added (ﬁve units of
enzyme per microgram DNA) and the DNA was incubated for an additional 3 h.
Digested DNA was precipitated with sodium acetate and ethanol, and 500 ng of
each digest were combined into one tube. Combined DNA was size selected by
electrophoresis on a 1% agarose Tris–borate–EDTA gel. A 100–300-bp gel slice was
excised using a sterile scalpel and gel-puriﬁed using Qiagen Qiaquick columns,
eluting in 30ml of Qiagen EB buffer. Library construction was performed using the
Illumina Genomic DNA Sample Kit (Illumina Inc., USA) with single-end adapters,
following the manufacturer’s instructions with the following changes. For the end
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repair reaction, T4 DNA polymerase and T4 polynucleotide kinase were excluded
and the Klenow DNA polymerase was diluted 1:5 in water, and 1 ml was used per
reaction. For single-end oligo adapter ligation, adapters were diluted 1:10 in water,
and 1 ml was used per reaction. After the second size selection, DNA was eluted in
36ml EB buffer using Qiagen Qiaquick columns, and 13 ml was used as a template
for PCR, using Illumina reagents and cycling conditions with 18 cycles. After
cleanup with Qiagen MinElute columns, each library was examined by spectro-
photometry (Nanodrop, Thermo Scientiﬁc, USA) and Agilent DNA Bioanalyzer
(Agilent, USA).
Calculation of MeDIP-seq scores for single CpGs. Raw MeDIP-seq sequences
were examined for quality, sample swap and reagent contamination using custom in
house scripts. Sequence reads were aligned to NCBI GRCh37-lite reference using
BWA 0.5.7 (ref. 34) and default parameters. To transform aligned MeDIP-seq
sequences to single CpG fractional calls for each library we calculated the MeDIP
coverage signal for CpGs genome wide and the average coverage in all genomic
regions, which were 4¼ 500 bp away from a CpG. The latter was used as a
background. Next, we convert signal and background values into the MeDIP
methylation score: a continuous value between 0 and 1 with a distribution very
similar to the one of whole-genome bisulphite sequencing (WGBS) fractional
methylation. During this process we exclude locations with mapability o0.5 and
correct for mapability for the locations with mapability between 0.5 and 1. After
MeDIP score assignment we assessed its speciﬁcity and sensitivity against WGBS
data sets and derived thresholds for hypomethylated (o0.35) and hypermethylated
(40.8) scores. The remaining CpGs were considered to have intermediate
methylation. These thresholds were used to analyse individual-speciﬁc and tissue-
speciﬁc methylation patterns and detect DMRs. For detected DMRs we calculate the
MRE signal (for the subset of CpGs where data are available) for cross validation.
Whole-genome bisulphite sequencing. Qubit quantiﬁed genomic DNA (1–5 mg)
was utilized for library construction. Unmethylated Lambda DNA (Promega, Cat
no. D1521) was added to genomic DNA for a 0.1% ﬁnal concentration. DNA was
sonicated to a fragment size ofB300 bp using a Bioruptor sonicator (Diagenode).
End-repair, addition of 30 A bases and adapter ligation was performed as per the
Illumina PE genomic DNA sample prep kit protocol except that methylated
cytosine PE adapters were used. Bisulﬁte conversion of puriﬁed adapter-ligated
DNA was performed using the EZ DNA Methylation Gold kit (ZymoResearch
Cat.D5005) according to the manufacturer’s instructions. The DNA was then
puriﬁed with the Qiagen Qiaquick kit, followed by PCR enrichment using Kapa
HiFi Hot Start UracilþReady (Kapa Biosystems, Cat no. KK2801) for ﬁve cycles
with PCR PE primers 1.0 and 2.0. PCR products were puriﬁed with the Qiagen
Minelute kit and size selected with PAGE gel puriﬁcation. DNA libraries were
checked for quantity by Qubit (Life Technologies) and quality by Agilent DNA
Bioanalyzer (Agilent). Libraries were sequenced using paired-end 100 nt sequen-
cing chemistry on an Illumina HiSeq 2000 following the manufacturer’s protocols
(Illumina).
Raw WGBS sequences were examined for quality, sample swap and reagent
contamination using custom in house scripts. Sequence reads were directionally
aligned to the human genome (GRCh37-lite) as described in ref. 36. UMRs were
detected using Cþ þ tool as described in ref. 21 with a P value o0.0005. The
median size of the identiﬁed UMRs wasB270 bp with ﬁve (median) differentially
methylated CpG per region.
Entropy-based thresholds. We used an entropy-based strategy to identify cell
type-speciﬁc expression events. In brief, for each comparison we have N mea-
surements (N cell types) for a given gene (for example, RPKM for lincRNAs, RPM
for miRs and so on): E_i(gene), with i¼ 1..N. We introduce a variable for every
gene called entropy (H) where H(gene)¼  sum(F_i *log2(F_i)), where index ’i’
runs over all cell types i¼ 1..N, and F¼E_i(gene)/sum(E_i(gene)). When H is
smallB0—the gene is expressed in just one cell type; if H is large andBlog2(N)—
this gene is expressed uniformly in all cell types. We introduce another quantity
’tissue speciﬁcity’, for a given gene for each cell types: Q(gene)_i¼H log2(F_i).
We next threshold our data in two-dimensional space: [H(gene), max(E_i(gene))]
to ensure that the gene is expressed in at least one cell type and has small entropy.
Thresholds are not independent; typically if gene has large expression, we have to
allow higher entropy. We cluster Q variable for all genes that pass the threshold to
generate heat maps.
cDNA synthesis for validations. The quality and yield of the isolated RNA (seven
samples plus Universal Human Reference total RNA control (Agilent Technolo-
gies, USA)) was assessed using Agilent 2100 Bioanalyzer (Agilent Technologies,
Santa Clara, CA, USA). PolyAþ RNA was puriﬁed using the 96-well MultiMACS
mRNA isolation kit on the MultiMACS 96 separator (Miltenyi Biotec, Germany)
with on-column DNaseI treatment as per the manufacturer’s instructions. The
eluted PolyAþ RNA was ethanol precipitated and resuspended in 8 ml of Nuclease
free water with 1:20 SuperaseIN (Life Technologies, USA). First strand cDNA was
synthesized from the puriﬁed polyAþ RNA using the Maxima H Minus First
Strand cDNA Synthesis Kit (Thermo Scientiﬁc, USA). Synthesis of the second-
strand cDNA was carried out in 50-ml reaction volume using second-strand
reagents from SuperScript double-stranded cDNA synthesis kit (Life Technologies,
USA). Double-stranded cDNA was quantiﬁed on Qubit Fluorometer using the
Qubit dsDNA HS assay (Life Technologies, USA). The quality of cDNA was
assesed on the Agilent Bioanalyzer using the high sensitivity DNA chip assay.
Intronic retention validation. Primers for the respective targets were designed
using Primer3 (primer3.sourceforge.net). The thermodynamic suitability of the
primer pairs was veriﬁed using the IDT Oligo Analyzer (Integrated DNA
Technologies, USA) and in silico PCR was carried out using the UCSC genome
browser to ensure primer speciﬁcity. Primers were synthesized by Integrated
DNA Technologies, USA and resuspended to 100mM stock with EB buffer
(Qiagen, USA).
To validate the primer pairs to be used in the downstream qPCR analysis a 50 ml
reaction was set up for each primer pair using 0.5 ml of Phusion HS II polymerase
(2U ml 1; Thermo Scientiﬁc), 10 ml of 5x HF buffer, 1.5 ml of DMSO, 1 ml of
10mM dNTPs, 0.25 ng of cDNA template, 2 ml of forward primer (10mM;
Integrated DNA Technologies, USA) and 2 ml of reverse primer (10mM; Integrated
DNA Technologies, USA). Each reaction was topped up to 50 ml with Ultrapure
water. The reactions were denatured at 98 C for 1min before 35 cycles at 98 C
(15 s)/64 C (15 s)/72 C (15 s) with a ﬁnal extension for 5min at 72 C. For
visualization, 10ml from each PCR reaction was diluted 1:2 with Ultrapure water,
loaded on a 1% Agarose E-gel (Invitrogen, USA) and run for 10min.
The qPCR assay was performed in MicroAmp Optical 384-well plates (Applied
Biosystems, USA) in a 10ml reaction volume in triplicate for each target using ViiA
7 Real-Time PCR System with 384-well heating block (Life Technologies, USA).
Each reaction contained: 5 ml of 2X SYBR Green PCR master mix (Life
Technologies, USA), 4 ml of primer mix (ﬁnal primer concentration 250 nM each)
and 1 ml of cDNA template (0.25 ng ml 1). The qPCR run method consisted of
98 C for 10min (‘hot start’) followed by 40 cycles of 98 C for 15 s (denaturation)
and 62 C for 1min (gene target ampliﬁcation).
The experimental suitability of each primer pair was veriﬁed by including non-
template control samples (to check primer-dimer formation in the experimental
conditions) and dissociation curves for the amplicons generated in the
experimental samples. A ﬁnal dissociation step was always performed at the end of
each PCR assay to verify the unique and speciﬁc ampliﬁcation of the target
sequence.
Fold changes were calculated with 2-DCt formula, where DCt is Ct(Intron–
Exon primers)—Ct(Exon–Exon primers). Fold changes were averaged across
triplicates and the s.d. was computed (outlier Ct values were excluded from the
mean calculation). Fold change was plotted against the intron retention level that is
the ratio between intron-level-normalized coverage and ﬂanking exon normalized
coverage (ratio was computed for both the ﬂanking exons and the averaged ratio is
reported). Fold change values that are o1 were replaced by  2DCt in this plot
(Supplementary Fig. 11) to aid interpretation.
Isoform junction PCR validation. Primers ﬂanking isoform junctions were
designed using Primer3 (primer3.sourceforge.net). The thermodynamic suitability
of the primer pairs was veriﬁed using the IDT Oligo Analyzer (Integrated DNA
Technologies, USA) and in silico PCR was carried out using the UCSC genome
browser to ensure primer speciﬁcity. Primers were synthesized by Integrated DNA
Technologies (USA) and resuspended to 100 mM stock concentration with EB
buffer (Qiagen, USA).
To validate the presence of the isoform junctions, a 50 ml PCR reaction was set
up using primers ﬂanking the junction under investigation. The reaction consisted
of 0.5 ml of Phusion HS II polymerase (1U; Thermo Scientiﬁc), 10 ml of 5x HF
buffer, 1.5 ml of DMSO, 1 ml of 10mM dNTPs, 0.5 ng of cDNA template, 2 ml of
forward primer (10mM; Integrated DNA Technology, USA) and 2 ml of reverse
primer (10mM; Integrated DNA Technologies, USA). Each reaction was topped up
to 50 ml with Ultrapure water (Invitrogen, USA). Conditions for PCR ampliﬁcation
were as follows: 98 C for 1min then 35 cycles at 98 C (15 s)/63 C (15 s)/72 C
(15 s) followed by a ﬁnal extension for 5min at 72 C. For visualization, 10ml from
each PCR reaction was diluted 1:2 with Ultrapure water, loaded onto a 1% Agarose
E-gel (Invitrogen, USA) and run for 10min.
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